Monoclonal Anti-Coxsackievirus A16 (strain G-10) VP0 Antibody, Human IgG1 (14E1) (MALS verified)
Produktgrößen
100 ug
£366,00
VP0-MY2108-100UG
1 mg
£2391,00
VP0-MY2108-1MG
Über dieses Produkt
- SKU:
- VP0-MY2108
- Buffer:
- PBS (pH 7.4)
- translate.label.attr.clone:
- 14E1
- Klonalität:
- Monoclonal
- Weitere Details:
- Cox A16 infection is very common in China, and the pathogenicity of Cox A16 is significantly different from enterovirus 71. Cox A16 can induce the production of a variety of micribonucleic acid, which affects the conduction of inflammatory signaling pathway, leading to the occurrence of pathological damage. Cox A16 capsid protein VP1, as an important target protein, interacts with host cell receptors to provide virion attachment to target host cells.
- Immunogen:
- VP0 (Coxsackievirus A16)
- Physischer Zustand:
- Powder
- Aufreinigung:
- 0.95
- Reaktivitäten:
- Mouse
- Versandbedingungen:
- Ambient
- Lagerbedingungen:
- -20[o]C
- Hersteller:
- ACRO Biosystems
- Typ:
- Antibody: Monoclonal Antibody
